Oncology

Case Study

Identify the Right Endpoints in Rare Disease Clinical Trial Design

May 19, 2026
Case Study

How to Increase Probability of Phase 3 Success in Oncology Trials

May 19, 2026
Case Study

How to Enable Earlier Decision-Making in Cancer Prevention Trials

May 19, 2026
Blog

5 Proven Strategies to Improve Recruitment and Reduce Patient Dropout in Clinical Trials 

April 10, 2025
Webinar

Does Real-World Evidence Have a Role in Precision Oncology?

November 9, 2023
Article

Trial Design for Cancer Immunotherapy: A Methodological Toolkit

October 4, 2023
Webinar

Good Morning Meeting | Optimizing the Transition From Early to Late Phase Trials in Oncology

September 19, 2023
Webinar

Supporting Shared Decision – Making and Communication in Breast Cancer: The ShareView Project

March 30, 2023
White Paper

Why Do So Many Phase III Fail?

December 12, 2022
Webinar

Conversation Between a Sponsor and a Statistician About Phase II/III Trials in Oncology

June 23, 2022

When every data point represents a patient, accuracy and integrity aren’t optional — they’re everything. That’s why it’s IDDI.

Start Now